Staphylococcal cell-wall peptidoglycan (PGN)

Staphylococcal cell-wall peptidoglycan is a vital structural heteropolymer that forms a mesh-like layer outside the cytoplasmic membrane of Staphylococcus species, including Staphylococcus aureus. It is composed of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues, which are cross-linked by pentaglycine bridges attached to short peptide side chains (Vollmer et al., 2008). Its primary biological role is to provide mechanical strength to the cell, maintaining osmotic stability and serving as a scaffold for the attachment of various virulence factors and surface proteins (Boneca, 2005). In clinical medicine, this molecule is a major pathogen-associated molecular pattern (PAMP) recognized by the host's innate immune system via receptors like NOD2, often triggering significant inflammatory responses during infection (Girardin et al., 2003). Peptidoglycan is the direct molecular target for glycopeptide antibiotics such as vancomycin, which bind to the D-alanyl-D-alanine terminus of its precursors to inhibit cell wall synthesis. The emergence of resistance, particularly through the modification of this target to D-alanyl-D-lactate, represents a critical challenge in treating multidrug-resistant Staphylococcal infections (McGuinness et al., 2017).

Other names

MureinStaphylococcal mureinBacterial cell wall peptidoglycanPeptidoglycan layer

Glycopeptide antibiotics bind directly to the D-alanyl-D-alanine (D-Ala-D-Ala) C-terminus of the peptidoglycan precursors, sterically hindering the transglycosylation and transpeptidation enzymes (Penicillin-Binding Proteins) from cross-linking the cell wall (StatPearls, 2023; Vollmer et al., 2008).